Abstract: The present disclosure relates to compounds, compositions, and methods for the treatment of primary hyperoxaluria type 1 and recurrent kidney stone formers. The present disclosure is directed to novel substituted heterocyclic carboxylate compounds and methods for their preparation and use as therapeutic or prophylactic agents. In particular, the present disclosure provides novel inhibitors of human glycolate oxidase enzyme, pharmaceutical compositions containing such compounds, and methods for using these compounds to treat primary hyperoxaluria type 1 and recurrent kidney stone formers.

Abstract: A method for the production of a highly water absorptive resin comprises the steps of neutralizing acrylic acid with alkali metal hydroxide to form an alkali metal acrylate; mixing the alkali metal acrylate, methacrylic acid, a polymerization initiator, and a first crosslinking agent; suspending and dispersing the mixture in an aqueous medium to for an initial mixture; polymerizing the initial mixture to produce a polymerized intermediate, and separating the moisture from the polymerized intermediate by azeotropic distillation to reduce the water content to 15-35% by weight; adding a second crosslinking agent, said second crosslinking agent having two epoxy radicals; and mixing "Syloid" of silicate, to form a highly water absorptive resin.